Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2023. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Mesalazine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has active ingredient | Mesalazine | false | Inferred relationship | Some | ||
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has manufactured dose form | Delayed-release tablet | false | Inferred relationship | Some | ||
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has manufactured dose form | Gastro-resistant oral tablet (dose form) | false | Inferred relationship | Some | ||
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has basis of strength substance (attribute) | Mesalazine | false | Inferred relationship | Some | 1 | |
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Is a | Product containing only mesalazine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has precise active ingredient | Mesalazine | false | Inferred relationship | Some | 1 | |
| Product containing precisely mesalazine 800 milligram/1 each gastro-resistant oral tablet (clinical drug) | Has presentation strength numerator value | 800 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
SAME AS association reference set (foundation metadata concept)
FHIR